Millennium Management LLC Sells 6,916 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Millennium Management LLC trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 54.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,685 shares of the company’s stock after selling 6,916 shares during the quarter. Millennium Management LLC’s holdings in VanEck Pharmaceutical ETF were worth $491,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Bank of America Corp DE lifted its position in VanEck Pharmaceutical ETF by 5.2% in the fourth quarter. Bank of America Corp DE now owns 109,237 shares of the company’s stock worth $9,425,000 after purchasing an additional 5,447 shares during the period. SBI Securities Co. Ltd. bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at approximately $29,000. JPMorgan Chase & Co. grew its stake in shares of VanEck Pharmaceutical ETF by 18.6% in the 4th quarter. JPMorgan Chase & Co. now owns 11,316 shares of the company’s stock valued at $976,000 after purchasing an additional 1,774 shares during the period. Raymond James Financial Inc. bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at approximately $1,323,000. Finally, Jones Financial Companies Lllp grew its stake in shares of VanEck Pharmaceutical ETF by 1,827.0% in the 4th quarter. Jones Financial Companies Lllp now owns 5,704 shares of the company’s stock valued at $492,000 after purchasing an additional 5,408 shares during the period.

VanEck Pharmaceutical ETF Trading Up 1.0%

PPH stock opened at $89.30 on Monday. The firm has a market cap of $557.23 million, a P/E ratio of 24.60 and a beta of 0.55. The business’s 50 day moving average is $85.75 and its 200-day moving average is $88.15. VanEck Pharmaceutical ETF has a 1-year low of $77.67 and a 1-year high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Shareholders of record on Tuesday, April 1st were issued a dividend of $0.5245 per share. The ex-dividend date was Tuesday, April 1st. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $2.10 dividend on an annualized basis and a dividend yield of 2.35%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.